Advancements in COPD Management: Singapore’s HSA Approves Revefenacin (Yupelri®)

revefenacin (Yupelri)

Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterised by irreversible airflow limitation and associated with significant morbidity and mortality. In 2014, COPD was ranked the 10

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

Madeline Stuart Model Down Syndrome

Down Syndrome Day: Celebrating the Abilities of People

World Down Syndrome Day is celebrated on March 21st each year to raise awareness and celebrate the abilities and accomplishments of individuals with Down Syndrome. Learn about the significance of this day, how it promotes inclusion and equality, and ways to challenge stereotypes and support the Down Syndrome community.

Read More »

People also read: